Jeffrey M. Dayno - Jan 24, 2025 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: PRESIDENT, CEO, Director
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Stock symbol: HRMY
Transactions as of: Jan 24, 2025
Transactions value $: -$173,592
Form type: 4
Date filed: 1/28/2025, 04:07 PM
Previous filing: Jan 23, 2025

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$0	+10.5K		$0.00	10.5K	Jan 24, 2025	Direct
transaction	HRMY	Common Stock	Tax liability	-$174K	-4.57K	-43.5%	$38.01	5.93K	Jan 24, 2025	Direct	F1

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Restricted Stock Units	Options Exercise	$0	-10.5K	-25%	$0.00	31.5K	Jan 24, 2025	Common Stock	10.5K		Direct	F2
transaction	HRMY	Stock Option	Award	$0	+180K		$0.00	180K	Jan 25, 2025	Common Stock	180K	$38.01	Direct	F3
transaction	HRMY	Restricted Stock Units	Award	$0	+52K		$0.00	52K	Jan 25, 2025	Common Stock	52K		Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
F2	This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
F3	The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
F4	The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.